Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT03599726

Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil

Sponsor: Medical Research Foundation, Oregon

Updated 7 times since 2018 Last updated: May 8, 2020 Started: Jul 30, 2018 Primary completion: May 30, 2019 Completion: Jul 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03599726, this EARLY_PHASE1 trial focuses on Parkinson Disease and remains completed. Sponsored by Medical Research Foundation, Oregon, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2020 — Jan 2021 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Aug 2019 — Jun 2020 [monthly]

Recruiting EARLY_PHASE1

▶ Show 2 earlier versions

Apr 2019 — Aug 2019 [monthly]

Recruiting EARLY_PHASE1
Aug 2018 — Apr 2019 [monthly]

Recruiting EARLY_PHASE1

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical Research Foundation, Oregon
Oregon Health and Science University

Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States